Opiant Pharmaceuticals Profit Margin

Opiant Pharmaceuticals (OPNT) currently reports a profit margin of -17.49% as of September 2022. That compares with 4.36% in the prior-year period — down 501.3% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Opiant Pharmaceuticals's profit margin history and peer comparisons.

Opiant Pharmaceuticals's profit margin decreased from 4.36% to -17.49% — a 501.3% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Opiant Pharmaceuticals's profit margin of -17.49% is lower than the Healthcare sector average of 13.89%. That is roughly 225.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Opiant Pharmaceuticals's current -17.49% should be judged against Healthcare norms (sector average: 13.89%) and against OPNT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -17.49%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Opiant Pharmaceuticals, and consider following OPNT for alerts when major investors trade the stock.